Found: 65
Select item for more details and to access through your institution.
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.
- Published in:
- Diabetologia, 2005, v. 48, n. 6, p. 1207, doi. 10.1007/s00125-005-1753-z
- By:
- Publication type:
- Article
DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population.
- Published in:
- Clinical Genetics, 1994, v. 46, n. 3, p. 248, doi. 10.1111/j.1399-0004.1994.tb04235.x
- By:
- Publication type:
- Article
PPAR-a and PPAR-? activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.
- Published in:
- Nature Medicine, 2001, v. 7, n. 1, p. 53, doi. 10.1038/83348
- By:
- Publication type:
- Article
Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APC<sup>Min</sup>/+ mice.
- Published in:
- Nature Medicine, 1998, v. 4, n. 9, p. 1053, doi. 10.1038/2036
- By:
- Publication type:
- Article
Peroxisome Proliferator-Activated Receptor-α Activation as a Mechanism of Preventive Neuroprotection Induced by Chronic Fenofibrate Treatment.
- Published in:
- Journal of Neuroscience, 2003, v. 23, n. 15, p. 6264, doi. 10.1523/JNEUROSCI.23-15-06264.2003
- By:
- Publication type:
- Article
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0864-7
- By:
- Publication type:
- Article
Sorting out the roles of PPARα in energy metabolism and vascular homeostasis.
- Published in:
- Journal of Clinical Investigation, 2006, v. 116, n. 3, p. 571, doi. 10.1172/JCI27989
- By:
- Publication type:
- Article
PPAR inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
- Published in:
- Journal of Clinical Investigation, 2005, v. 115, n. 11, p. 3228, doi. 10.1172/JCI22756
- By:
- Publication type:
- Article
Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Apolipoprotein A-V Modulates Insulin Secretion in Pancreatic β-cells Through its Interaction with Midkine.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2009, v. 24, n. 5/6, p. 451, doi. 10.1159/000257484
- By:
- Publication type:
- Article
The orphan nuclear receptor RORa is a negative regulator of the inflammatory response.
- Published in:
- EMBO Reports, 2001, v. 2, n. 1, p. 42, doi. 10.1093/embo-reports/kve007
- By:
- Publication type:
- Article
[4-(2 H-1,2,3-Benzotriazol-2-yl)phenoxy]alkanoic Acids as Agonists of Peroxisome Proliferator-Activated Receptors (PPARs).
- Published in:
- Chemistry & Biodiversity, 2006, v. 3, n. 4, p. 385, doi. 10.1002/cbdv.200690042
- By:
- Publication type:
- Article
Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 9, p. 1133, doi. 10.1515/CCLM.2007.257
- By:
- Publication type:
- Article
Regulation of Lipid and Lipoprotein Metabolism by PPAR Activators.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2000, v. 38, n. 1, p. 3
- By:
- Publication type:
- Article
Melatonin related compounds inhibit lipid peroxidation during copper or free radical-induced LDL oxidation.
- Published in:
- Journal of Pineal Research, 2002, v. 33, n. 2, p. 109, doi. 10.1034/j.1600-079X.2002.02911.x
- By:
- Publication type:
- Article
Lessons from PROMINENT and prospects for pemafibrate.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Adipophilin increases triglyceride storage in human macrophages by stimulation of biosynthesis and inhibition of β-oxidation.
- Published in:
- FEBS Journal, 2006, v. 273, n. 15, p. 3498, doi. 10.1111/j.1742-4658.2006.05357.x
- By:
- Publication type:
- Article
Di- tert-butylhydroxylated flavonoids protect endothelial cells against oxidized LDL-induced cytotoxicity.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2001, v. 15, n. 5, p. 270, doi. 10.1002/jbt.10003
- By:
- Publication type:
- Article
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 1, p. 1, doi. 10.1007/s11883-020-00897-x
- By:
- Publication type:
- Article
Selective Peroxisome Proliferator–Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 8, p. 1, doi. 10.1007/s11883-020-00860-w
- By:
- Publication type:
- Article
Peroxisome proliferator activated receptors and stroke.
- Published in:
- Current Atherosclerosis Reports, 2003, v. 5, n. 5, p. 331, doi. 10.1007/s11883-003-0001-6
- By:
- Publication type:
- Article
HMG CoA reductase inhibitors and PPAR-α activators: Are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials?
- Published in:
- Current Atherosclerosis Reports, 2002, v. 4, n. 6, p. 403, doi. 10.1007/s11883-002-0041-3
- By:
- Publication type:
- Article
The role of fibric acids in atherosclerosis.
- Published in:
- Current Atherosclerosis Reports, 2001, v. 3, n. 1, p. 83, doi. 10.1007/s11883-001-0015-x
- By:
- Publication type:
- Article
Are nuclear factors the ultimate targets of drugs affecting lipid metabolism?
- Published in:
- Current Atherosclerosis Reports, 2000, v. 2, n. 5, p. 353, doi. 10.1007/s11883-000-0071-7
- By:
- Publication type:
- Article
Recent developments in the treatment of hypertriglyceridemia.
- Published in:
- Current Atherosclerosis Reports, 1999, v. 1, n. 1, p. 31, doi. 10.1007/s11883-999-0047-1
- By:
- Publication type:
- Article
PPARs: Transcription Factors Controlling Lipid and Lipoprotein Metabolism.
- Published in:
- Annals of the New York Academy of Sciences, 2002, v. 967, n. 1, p. 7, doi. 10.1111/j.1749-6632.2002.tb04258.x
- By:
- Publication type:
- Article
Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0602-y
- By:
- Publication type:
- Article
Residual macrovascular risk in 2013: what have we learned?
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 3, doi. 10.1186/1475-2840-13-26
- By:
- Publication type:
- Article
Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists.
- Published in:
- Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-82
- By:
- Publication type:
- Article
Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-64902-8
- By:
- Publication type:
- Article
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 13, p. 1556, doi. 10.1001/jama.295.13.jpc60002
- By:
- Publication type:
- Article
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients.
- Published in:
- Diabetes & Vascular Disease Research, 2008, v. 5, n. 4, p. 319, doi. 10.3132/dvdr.2008.046
- By:
- Publication type:
- Article
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes.
- Published in:
- Diabetes Care, 2006, v. 29, n. 6, p. 1220, doi. 10.2337/dc05-2465
- By:
- Publication type:
- Article
Glucose regulates LXRα subcellular localization and function in rat pancreatic β-cells.
- Published in:
- Cell Research, 2006, v. 16, n. 7, p. 661, doi. 10.1038/sj.cr.7310069
- By:
- Publication type:
- Article
Phenylpropanoids from Ballota nigra L. inhibit in vitro LDL peroxidation.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Postprandial Dyslipidemia: A Risk Factor for Coronary Heart Disease.
- Published in:
- Annals of Nutrition & Metabolism, 1998, v. 42, n. 1, p. 1, doi. 10.1159/000012712
- By:
- Publication type:
- Article
Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation on lipoprotein metabolism in the rat.
- Published in:
- Lipids, 1999, v. 34, n. 1, p. 39, doi. 10.1007/s11745-999-335-2
- By:
- Publication type:
- Article
Apolipoprotein E Knockout Mice Over-Expressing Human Tissue Inhibitor of Metalloproteinase 1 Are Protected against Aneurysm Formation but Not against Atherosclerotic Plaque Development.
- Published in:
- Journal of Vascular Research, 2006, v. 43, n. 6, p. 493, doi. 10.1159/000095309
- By:
- Publication type:
- Article
Peroxisome Proliferator--Activated Receptor α Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets.
- Published in:
- Diabetes, 2006, v. 55, n. 6, p. 1605, doi. 10.2337/db06-0016
- By:
- Publication type:
- Article
Therapeutic roles of peroxisome proliferator-activated receptor agonists.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Therapeutic Roles of Peroxisome Proliferator--Activated Receptor Agonists.
- Published in:
- Diabetes, 2005, v. 54, n. 8, p. 2460, doi. 10.2337/diabetes.54.8.2460
- By:
- Publication type:
- Article
Glucose regulates the expression of the farnesoid X receptor in liver.
- Published in:
- 2004
- By:
- Publication type:
- journal article
PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Apolipoprotein A-I-containing particles and reverse cholesterol transport in IDDM.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 4, p. 720, doi. 10.3390/cells11040720
- By:
- Publication type:
- Article
Neutral-lipid transfers and cholesteryl ester transfer protein in hemodialyzed patients.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Apolipoprotein AI and apolipoprotein B containing particle analysis in normolipidemic hemodialyzed patients: evidence of free apolipoprotein E.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Drug Transfer Across the Blood-Brain Barrier: Correlation Between In Vitro and In Vivo Models.
- Published in:
- Journal of Neurochemistry, 1992, v. 58, n. 5, p. 1790, doi. 10.1111/j.1471-4159.1992.tb10055.x
- By:
- Publication type:
- Article
Bovine Brain Endothelial Cells Express Tight Junctions and Monoamine Oxidase Activity in Long-Term Culture.
- Published in:
- Journal of Neurochemistry, 1989, v. 53, n. 5, p. 1363, doi. 10.1111/j.1471-4159.1989.tb08526.x
- By:
- Publication type:
- Article
Low-Density Lipoprotein Receptor on Endothelium of Brain Capillaries.
- Published in:
- Journal of Neurochemistry, 1989, v. 53, n. 2, p. 340, doi. 10.1111/j.1471-4159.1989.tb07340.x
- By:
- Publication type:
- Article